Mechanistic Insights into Vascular Biology Via Methyltransferase-like 3-driven N-adenosine Methylation of RNA

Overview

Journal Front Cell Dev Biol

Date 2025 Jan 21

PMID 39834386

Authors

Deshuang Zhang

Zhixian Gou

Yi Qu

Xiaojuan Su

Affiliations

Soon will be listed here.

Abstract

Recent advancements in the mechanistic comprehension of vascular biology have concentrated on METTL3-mediated N-methyladenosine modification of RNA, which modulates a spectrum of RNA functionalities with precision. Despite extensive investigations into the roles and mechanisms of METTL3 within vascular biology, a holistic review elucidating their interconnections remains absent. This analysis endeavors to meticulously scrutinize the involvement of METTL3 in both the physiological and pathological paradigms of vascular biology. The findings of this review indicate that METTL3 is indispensable for vascular development and functionality, predominantly through its regulatory influence on pericytes, endothelial cells, vascular smooth muscle cells, and hematopoietic stem cells. Conversely, aberrant METTL3 activity is implicated as a risk factor, diagnostic biomarker, and therapeutic target for vascular pathologies. This comprehensive review offers an exhaustive synthesis of METTL3's role in vascular biology, addressing existing knowledge gaps and serving as an essential reference for future research and potential clinical applications.

References

Petri B, Klinge C . m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. J Mol Endocrinol. 2022; 70(2). PMC: 9790079. DOI: 10.1530/JME-22-0110. View

Ponmozhi J, Dhinakaran S, Kocsis D, Ivan K, Erdo F . Models for barrier understanding in health and disease in lab-on-a-chips. Tissue Barriers. 2023; 12(2):2221632. PMC: 11042069. DOI: 10.1080/21688370.2023.2221632. View

Liu B, Yang H, Song Y, Sorenson C, Sheibani N . Thrombospondin-1 in vascular development, vascular function, and vascular disease. Semin Cell Dev Biol. 2023; 155(Pt B):32-44. PMC: 10811293. DOI: 10.1016/j.semcdb.2023.07.011. View

Scalise A, Kakogiannos N, Zanardi F, Iannelli F, Giannotta M . The blood-brain and gut-vascular barriers: from the perspective of claudins. Tissue Barriers. 2021; 9(3):1926190. PMC: 8489939. DOI: 10.1080/21688370.2021.1926190. View

Fevereiro-Martins M, Marques-Neves C, Guimaraes H, Bicho M . Retinopathy of prematurity: A review of pathophysiology and signaling pathways. Surv Ophthalmol. 2022; 68(2):175-210. DOI: 10.1016/j.survophthal.2022.11.007. View

Bai Q, Lu Y, Chen Y, Zhang H, Zhang W, Wu H . Endothelial METTL3 (Methyltransferase-Like 3) Inhibits Fibrinolysis by Promoting PAI-1 (Plasminogen Activator Inhibitor-1) Expression Through Enhancing Jun Proto-Oncogene N6-Methyladenosine Modification. Arterioscler Thromb Vasc Biol. 2021; 41(12):2877-2889. PMC: 8608005. DOI: 10.1161/ATVBAHA.121.316414. View

Luo H, Liu W, Zhou Y, Zhang Y, Wu J, Wang R . Stage-specific requirement for METTL3-dependent mA modification during dental pulp stem cell differentiation. J Transl Med. 2022; 20(1):605. PMC: 9756505. DOI: 10.1186/s12967-022-03814-9. View

Stepp M, Menko A . Immune responses to injury and their links to eye disease. Transl Res. 2021; 236:52-71. PMC: 8380715. DOI: 10.1016/j.trsl.2021.05.005. View

Zhang C, Chen Y, Sun B, Wang L, Yang Y, Ma D . mA modulates haematopoietic stem and progenitor cell specification. Nature. 2017; 549(7671):273-276. DOI: 10.1038/nature23883. View

10.

Heath Jeffery R, Chen F . Macular neovascularization in inherited retinal diseases: A review. Surv Ophthalmol. 2023; 69(1):1-23. DOI: 10.1016/j.survophthal.2023.07.007. View

11.

Chakraborty A, Li Y, Zhang C, Li Y, Rebello K, Li S . Epigenetic Induction of Smooth Muscle Cell Phenotypic Alterations in Aortic Aneurysms and Dissections. Circulation. 2023; 148(12):959-977. PMC: 10529114. DOI: 10.1161/CIRCULATIONAHA.123.063332. View

12.

Wang J, Wang J, Gu Q, Ma Y, Yang Y, Zhu J . The biological function of m6A demethylase ALKBH5 and its role in human disease. Cancer Cell Int. 2020; 20:347. PMC: 7388453. DOI: 10.1186/s12935-020-01450-1. View

13.

Zhong L, He X, Song H, Sun Y, Chen G, Si X . METTL3 Induces AAA Development and Progression by Modulating N6-Methyladenosine-Dependent Primary miR34a Processing. Mol Ther Nucleic Acids. 2020; 21:394-411. PMC: 7347714. DOI: 10.1016/j.omtn.2020.06.005. View

14.

Zhang M, Yang C, Ruan X, Liu X, Wang D, Liu L . CPEB2 m6A methylation regulates blood-tumor barrier permeability by regulating splicing factor SRSF5 stability. Commun Biol. 2022; 5(1):908. PMC: 9445078. DOI: 10.1038/s42003-022-03878-9. View

15.

Cheng Y, Luo H, Izzo F, Pickering B, Nguyen D, Myers R . mA RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment. Cell Rep. 2019; 28(7):1703-1716.e6. PMC: 6818972. DOI: 10.1016/j.celrep.2019.07.032. View

16.

Lu Y, Wang S, Cai S, Gu X, Wang J, Yang Y . Propofol-induced MiR-20b expression initiates endogenous cellular signal changes mitigating hypoxia/re-oxygenation-induced endothelial autophagy in vitro. Cell Death Dis. 2020; 11(8):681. PMC: 7442825. DOI: 10.1038/s41419-020-02828-9. View

17.

Wang W, Ye W, Chen S, Tang Y, Chen D, Lu Y . METTL3-mediated mA RNA modification promotes corneal neovascularization by upregulating the canonical Wnt pathway during HSV-1 infection. Cell Signal. 2023; 109:110784. DOI: 10.1016/j.cellsig.2023.110784. View

18.

Patti G, Cavallari I, Cesaro A, Gragnano F, Riva L, Fimiani F . Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology. Vascul Pharmacol. 2022; 148:107137. DOI: 10.1016/j.vph.2022.107137. View

19.

Yao M, Jiang Q, Ma Y, Liu C, Zhu C, Sun Y . Role of METTL3-Dependent N-Methyladenosine mRNA Modification in the Promotion of Angiogenesis. Mol Ther. 2020; 28(10):2191-2202. PMC: 7545007. DOI: 10.1016/j.ymthe.2020.07.022. View

20.

Luo H, Wu X, Huo B, Liu L, Jiang D, Yi X . The roles of METTL3 on autophagy and proliferation of vascular smooth muscle cells are mediated by mTOR rather than by CDK1. Cell Div. 2023; 18(1):13. PMC: 10411010. DOI: 10.1186/s13008-023-00096-5. View